Biotechnology valuation: an introductory guide
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Chichester, England
John Wiley & Sons
©2008
|
Schriftenreihe: | Wiley finance
|
Schlagworte: | |
Online-Zugang: | FRO01 UBG01 Volltext Buchcover |
Beschreibung: | Includes bibliographical references (pages 189-192) and index "This book is a hands-on guide to the valuation of biotechnology companies both from a private and public market perspective for industry professionals, investors and students." "By highlighting some of the most common pitfalls of biotechnology valuation and providing a toolkit to establishing the value of a biotechnology company, this book will enable the reader to develop a consistent approach and have a useful toolkit to tackle the valuation of a biotechnology company or individual drug, with confidence."--Jacket |
Beschreibung: | 1 Online-Ressource (ix, 206 pages) |
ISBN: | 9780470741344 0470741341 9781118673508 1118673506 1282349384 9781282349384 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043389454 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 160222s2008 |||| o||u| ||||||eng d | ||
020 | |a 9780470741344 |c electronic bk. |9 978-0-470-74134-4 | ||
020 | |a 0470741341 |c electronic bk. |9 0-470-74134-1 | ||
020 | |a 9781118673508 |c electronic bk. |9 978-1-118-67350-8 | ||
020 | |a 1118673506 |c electronic bk. |9 1-118-67350-6 | ||
020 | |a 1282349384 |9 1-282-34938-4 | ||
020 | |a 9781282349384 |9 978-1-282-34938-4 | ||
024 | 7 | |a 10.1002/9781118673508 |2 doi | |
035 | |a (ZDB-35-WIC)ocn313862959 | ||
035 | |a (OCoLC)313862959 | ||
035 | |a (DE-599)BVBBV043389454 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-861 | ||
082 | 0 | |a 332.63/221 |2 22 | |
100 | 1 | |a Keegan, Karl D. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Biotechnology valuation |b an introductory guide |c Karl D. Keegan |
264 | 1 | |a Chichester, England |b John Wiley & Sons |c ©2008 | |
300 | |a 1 Online-Ressource (ix, 206 pages) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Wiley finance | |
500 | |a Includes bibliographical references (pages 189-192) and index | ||
500 | |a "This book is a hands-on guide to the valuation of biotechnology companies both from a private and public market perspective for industry professionals, investors and students." "By highlighting some of the most common pitfalls of biotechnology valuation and providing a toolkit to establishing the value of a biotechnology company, this book will enable the reader to develop a consistent approach and have a useful toolkit to tackle the valuation of a biotechnology company or individual drug, with confidence."--Jacket | ||
650 | 7 | |a BUSINESS & ECONOMICS / Investments & Securities / Stocks |2 bisacsh | |
650 | 4 | |a Wirtschaft | |
650 | 4 | |a Biotechnology industries / Valuation | |
650 | 4 | |a Pharmaceutical industry / Valuation | |
650 | 4 | |a Investment analysis | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-470-51178-7 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-470-51178-8 |
856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118673508 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
856 | 4 | 2 | |m SWB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028808038&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Buchcover |
912 | |a ZDB-35-WIC | ||
940 | 1 | |q UBG_PDA_WIC | |
999 | |a oai:aleph.bib-bvb.de:BVB01-028808038 | ||
966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118673508 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118673508 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804175962542178304 |
---|---|
any_adam_object | 1 |
author | Keegan, Karl D. |
author_facet | Keegan, Karl D. |
author_role | aut |
author_sort | Keegan, Karl D. |
author_variant | k d k kd kdk |
building | Verbundindex |
bvnumber | BV043389454 |
collection | ZDB-35-WIC |
ctrlnum | (ZDB-35-WIC)ocn313862959 (OCoLC)313862959 (DE-599)BVBBV043389454 |
dewey-full | 332.63/221 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 332 - Financial economics |
dewey-raw | 332.63/221 |
dewey-search | 332.63/221 |
dewey-sort | 3332.63 3221 |
dewey-tens | 330 - Economics |
discipline | Wirtschaftswissenschaften |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02893nmm a2200541zc 4500</leader><controlfield tag="001">BV043389454</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470741344</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-74134-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470741341</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-74134-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118673508</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-118-67350-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1118673506</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-118-67350-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282349384</subfield><subfield code="9">1-282-34938-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282349384</subfield><subfield code="9">978-1-282-34938-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9781118673508</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn313862959</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)313862959</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043389454</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">332.63/221</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Keegan, Karl D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biotechnology valuation</subfield><subfield code="b">an introductory guide</subfield><subfield code="c">Karl D. Keegan</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester, England</subfield><subfield code="b">John Wiley & Sons</subfield><subfield code="c">©2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (ix, 206 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Wiley finance</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 189-192) and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"This book is a hands-on guide to the valuation of biotechnology companies both from a private and public market perspective for industry professionals, investors and students." "By highlighting some of the most common pitfalls of biotechnology valuation and providing a toolkit to establishing the value of a biotechnology company, this book will enable the reader to develop a consistent approach and have a useful toolkit to tackle the valuation of a biotechnology company or individual drug, with confidence."--Jacket</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Investments & Securities / Stocks</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology industries / Valuation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / Valuation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Investment analysis</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-470-51178-7</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-470-51178-8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118673508</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">SWB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028808038&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Buchcover</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028808038</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118673508</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118673508</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV043389454 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:24:37Z |
institution | BVB |
isbn | 9780470741344 0470741341 9781118673508 1118673506 1282349384 9781282349384 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028808038 |
oclc_num | 313862959 |
open_access_boolean | |
owner | DE-861 |
owner_facet | DE-861 |
physical | 1 Online-Ressource (ix, 206 pages) |
psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | John Wiley & Sons |
record_format | marc |
series2 | Wiley finance |
spelling | Keegan, Karl D. Verfasser aut Biotechnology valuation an introductory guide Karl D. Keegan Chichester, England John Wiley & Sons ©2008 1 Online-Ressource (ix, 206 pages) txt rdacontent c rdamedia cr rdacarrier Wiley finance Includes bibliographical references (pages 189-192) and index "This book is a hands-on guide to the valuation of biotechnology companies both from a private and public market perspective for industry professionals, investors and students." "By highlighting some of the most common pitfalls of biotechnology valuation and providing a toolkit to establishing the value of a biotechnology company, this book will enable the reader to develop a consistent approach and have a useful toolkit to tackle the valuation of a biotechnology company or individual drug, with confidence."--Jacket BUSINESS & ECONOMICS / Investments & Securities / Stocks bisacsh Wirtschaft Biotechnology industries / Valuation Pharmaceutical industry / Valuation Investment analysis Erscheint auch als Druck-Ausgabe, Hardcover 978-0-470-51178-7 Erscheint auch als Druck-Ausgabe, Hardcover 0-470-51178-8 https://onlinelibrary.wiley.com/doi/book/10.1002/9781118673508 Verlag URL des Erstveröffentlichers Volltext SWB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028808038&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Buchcover |
spellingShingle | Keegan, Karl D. Biotechnology valuation an introductory guide BUSINESS & ECONOMICS / Investments & Securities / Stocks bisacsh Wirtschaft Biotechnology industries / Valuation Pharmaceutical industry / Valuation Investment analysis |
title | Biotechnology valuation an introductory guide |
title_auth | Biotechnology valuation an introductory guide |
title_exact_search | Biotechnology valuation an introductory guide |
title_full | Biotechnology valuation an introductory guide Karl D. Keegan |
title_fullStr | Biotechnology valuation an introductory guide Karl D. Keegan |
title_full_unstemmed | Biotechnology valuation an introductory guide Karl D. Keegan |
title_short | Biotechnology valuation |
title_sort | biotechnology valuation an introductory guide |
title_sub | an introductory guide |
topic | BUSINESS & ECONOMICS / Investments & Securities / Stocks bisacsh Wirtschaft Biotechnology industries / Valuation Pharmaceutical industry / Valuation Investment analysis |
topic_facet | BUSINESS & ECONOMICS / Investments & Securities / Stocks Wirtschaft Biotechnology industries / Valuation Pharmaceutical industry / Valuation Investment analysis |
url | https://onlinelibrary.wiley.com/doi/book/10.1002/9781118673508 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028808038&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT keegankarld biotechnologyvaluationanintroductoryguide |